Success Story: I-140 NIW Approval In 50 Days For An Internal Medicine Researcher With Premium Processing Service And Our Assistance

Client’s Testimonial:

 

"Amazing news! Thank you so much for all your help throughout this process!”

 


 

On June 18th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Resident in the Field of Internal Medicine (Approval Notice).

 


 

General Field: Internal Medicine

 

Position at the Time of Case Filing: Resident

 

Country of Origin: Mexico

 

State of Residence at the Time of Case Filing: New York

 

Approval Notice Date: June 18th, 2026

 

Processing Time: 1 month, 20 days (Premium Processing Requested)

 


 

Case Summary:

 

Chronic and immune-mediated diseases continue to create major challenges for patients, physicians, and public health systems. For this client, the central question was how large-scale clinical and genomic data could be translated into more precise prevention, diagnosis, and management strategies, especially for populations that have historically faced disparities in care.

 

We are pleased to share that the client’s I-140 NIW petition was approved in 50 days, with premium processing requested at filing. The client is an expert in internal medicine whose proposed endeavor is to continue analyzing large-scale clinical and genomic datasets to identify drivers of chronic and immune-mediated diseases. Through this work, the client aims to improve disease prevention, diagnosis, and management, inform evidence-based clinical guidelines, and reduce health disparities across underserved populations.

 

The client is currently employed as an internal medicine resident. In the petition, we emphasized that the client’s proposed endeavor was not limited to a single position or employer. Instead, we framed the work as a broader research effort with practical value for clinical medicine, public health, and health equity.

 

The petition explained that the client’s research uses large datasets to study patterns in chronic disease, immune-mediated disease, cancer disparities, allergy-related conditions, and clinical decision-making. We demonstrated that this work has substantial merit because it addresses the need for more accurate, evidence-based approaches to patient care. We also showed national importance by connecting the client’s research to broader U.S. healthcare needs, including the burden of chronic disease, the use of health data to improve outcomes, and the importance of reducing disparities among underserved populations.

 

To show that the client was well-positioned to advance the proposed endeavor, we presented a record of scholarly productivity and professional recognition. The client had authored 29 peer-reviewed journal articles, including 8 first-authored articles, along with 39 abstracts, including 10 first-authored abstracts. Rather than treating these numbers as automatically sufficient, we explained how an adjudicator could view them as evidence of sustained research activity across multiple areas of internal medicine and related clinical research.

 

The client’s published body of work had received 154 citations. In the petition, we framed the citation record as evidence that other researchers had independently used the client’s findings when developing their own work. The client had also completed at least 28 peer reviews. We used this evidence to support the argument that the client had earned peer trust.

 

We also included evidence of major funding sources connected to the client’s research, including the National Cancer Institute and the National Institutes of Health. Together, the publication record, citation evidence, peer review service, funded research context, and proposed future work allowed us to present the client as a researcher whose contributions were both meaningful and likely to continue benefiting the field.

 

The petition was supported by 4 recommendation letters from experts in the field. These letters helped explain the client’s research accomplishments, the importance of the proposed endeavor, and the ways the client’s work contributes to internal medicine, data-driven clinical research, and more equitable healthcare. One expert noted: “Together with his impressive record of publications, [Client] continues to make invaluable contributions to advancing equitable healthcare and strengthening the field of internal medicine.”

 

This approval reflects a petition strategy focused on more than listing credentials. By connecting his research record to a proposed endeavor in internal medicine that addresses chronic and immune-mediated diseases, clinical guidelines, and health disparities, we showed that the client was well-positioned to continue work with substantial merit and national importance. We congratulate the client on this I-140 NIW approval and wish the client continued success in advancing research that supports more precise and equitable patient care.